The FDA Breakthrough-Drug Designation — Four Years of Experience
Year: 2018
Type: editorial
Source: New England Journal of Medicine
Institutions: Brigham and Women's Hospital, Harvard University
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: closed
OpenAlex ID: W2798213862